Denali Therapeutics (DNLI) Enterprise Value (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.80% |
| Dec 31, 2025 | -2.32% |
| Sep 30, 2025 | 5.65% |
| Jun 30, 2025 | -9.91% |
| Mar 31, 2025 | 1.73% |
| Dec 31, 2024 | 0.51% |
| Sep 30, 2024 | 6.64% |
| Jun 30, 2024 | 4.36% |
| Mar 31, 2024 | 9.44% |
| Dec 31, 2023 | 6.74% |
| Sep 30, 2023 | 6.86% |
| Jun 30, 2023 | 7.56% |
| Mar 31, 2023 | 3.57% |
| Dec 31, 2022 | -20.81% |
| Sep 30, 2022 | -3.50% |
| Jun 30, 2022 | -11.61% |
| Mar 31, 2022 | -10.64% |
| Dec 31, 2021 | 16.72% |
| Sep 30, 2021 | 20.61% |
| Jun 30, 2021 | 7.37% |
| Mar 31, 2021 | 3.85% |
| Dec 31, 2020 | -52.90% |
| Sep 30, 2020 | -74.90% |
| Jun 30, 2020 | 6.41% |
| Mar 31, 2020 | -41.38% |
| Dec 31, 2019 | 13.36% |
| Sep 30, 2019 | -0.16% |
| Jun 30, 2019 | 1.42% |
| Mar 31, 2019 | -4.56% |
| Dec 31, 2018 | -23.83% |
| Sep 30, 2018 | -0.64% |
| Jun 30, 2018 | 0.22% |
| Mar 31, 2018 | 8.08% |
| Dec 31, 2017 | -1,020.04% |
| Sep 30, 2017 | 12.20% |
| Jun 30, 2017 | -12.40% |